Puma Biotech (PBYI) Reports Q4 Loss of $1.23/Share

Puma Biotech (NYSE: PBYI) reported Q4 EPS of ($1.23), versus ($1.03) reported last year.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• The LGL Group (LGL) Misses Q2 EPS by 8c
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance